1、MAY202 5Adopting New Therapies as Modalities Shift and Expenditures RiseGlobal Oncology Trends 2025As a leading cause of premature death globally,cancer remains an important area for continued investment in screening and early diagnosis,access to care,and novel treatment modalities with improved cli

2、nical benefits.As a result,the innovation ecosystem that discovers,develops,and delivers breakthrough therapies continues to operate near peak levels and treatment in developed countries is shifting toward newer modalities.However,these shifts may further exacerbate disparities in access to cancer c

3、are in low-and middle-income countries and across demographic groups.Our research profiles the current state of research and development in oncology,including key mechanisms,targets,and cancer types being investigated as well as pointing to some novel areas which are only just emerging.We also look

4、at metrics of clinical development productivity.As more novel cancer medicines are launched,patient access and use of those drugs vary widely around the world.Trends in the use of novel mechanisms in specific cancer types are reported here and intended to provide an evidence base that encourages sta

5、keholder discussion.Finally,the costs associated with treating more patients for longer and with more advanced therapies is bringing stress to healthcare budgets,even as the broader adoption of biosimilars provides some relief and will play an important role in the years to come.How these spending d

6、ynamics will play out over the next five years globally is also examined in this report.This study was produced independently by the IQVIA Institute for Human Data Science as a public service,without industry or government funding.The contributions to this report of Srinidhi BC,Saksham Bhardwaj,Tany